"This brief review captures the evolving role of miRNAs, focusing on their clinical relevance and implications as well as future directions for more effective targeted therapeutic interventions," write the authors.
Sarah Murray, PhD, FACMG
Advertisement
Articles by Sarah Murray, PhD, FACMG
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
Sean P. Collins, MD, PhD, outlines the impact of rectal spacers for men with prostate cancer
2
ORIC-944 shows promise in combination with ARPIs for mCRPC
3
Jason Hafron, MD, recaps prostate cancer data from ESMO 2025
4
Community practice experience shows early efficacy, favorable safety with nadofaragene
5
